Benefit-Risk Appraisal of MedicinesAuthor :
Hardback
Published : Wednesday 26 August 2009
Description
Establishes the criteria required to assess benefit-risk in general and reviews the current practice of benefit-risk assessment by drug regulatory authorities and the pharmaceutical industry. Outlines how the new MCDA model was developed and evaluated, and discusses the implications of its implementation into the practice of drug evaluation.
You may also like ...
![Product](https://jackets.dmmserver.com/media/140/97804700/9780470060858.jpg)
by
Hardback
26 Aug 2009
Medical research
€111.09
Extended stock – Dispatch 5-7 days
![Product](https://abcbooksimages.s3.eu-west-1.amazonaws.com/sBookimagesFlat2020/9781775842743.jpg)
by
Paperback
01 Jul 2017
Wildlife: mammals: general interest
€20.48
Extended stock – Dispatch 5-7 days
![Product](https://abcbooksimages.s3.eu-west-1.amazonaws.com/sBookimagesFlat2020/9781624650192.jpg)
by
Paperback
15 Dec 2014
Design, Industrial and commercial arts, illustration
€51.47
Extended stock – Dispatch 5-7 days
![Product](https://abcbooksimages.s3.eu-west-1.amazonaws.com/sBookimagesFlat2020/9780857241115.jpg)
by
Hardback
18 Jun 2010
Cognition and cognitive psychology
€100.61
Extended stock – Dispatch 5-7 days
Reviews